Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Jumonji Domain-Containing Histone Demethylases | 6 | 2020 | 43 | 1.970 |
Why?
|
| DNA-Binding Proteins | 5 | 2020 | 491 | 1.710 |
Why?
|
| Transcription Factors | 5 | 2020 | 522 | 1.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2020 | 464 | 1.260 |
Why?
|
| Prostatic Neoplasms | 3 | 2019 | 277 | 0.920 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2013 | 18 | 0.800 |
Why?
|
| Colorectal Neoplasms | 2 | 2020 | 139 | 0.760 |
Why?
|
| Smad Proteins | 1 | 2019 | 18 | 0.630 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2019 | 60 | 0.600 |
Why?
|
| 14-3-3 Proteins | 1 | 2013 | 9 | 0.420 |
Why?
|
| Exoribonucleases | 1 | 2013 | 20 | 0.420 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 406 | 0.410 |
Why?
|
| Adenovirus E1A Proteins | 1 | 2012 | 6 | 0.390 |
Why?
|
| Embryonic Development | 1 | 2012 | 21 | 0.380 |
Why?
|
| Oncogene Proteins | 1 | 2012 | 23 | 0.380 |
Why?
|
| Embryo, Mammalian | 1 | 2012 | 29 | 0.380 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 140 | 0.360 |
Why?
|
| Cell Proliferation | 5 | 2020 | 804 | 0.280 |
Why?
|
| Matrix Metalloproteinase 1 | 2 | 2020 | 16 | 0.280 |
Why?
|
| HEK293 Cells | 2 | 2019 | 187 | 0.250 |
Why?
|
| Cell Line | 3 | 2019 | 694 | 0.250 |
Why?
|
| HCT116 Cells | 3 | 2020 | 53 | 0.240 |
Why?
|
| Mutation | 2 | 2020 | 848 | 0.210 |
Why?
|
| Matrix Metalloproteinase 7 | 2 | 2013 | 13 | 0.210 |
Why?
|
| Mice, Knockout | 2 | 2019 | 845 | 0.200 |
Why?
|
| Down-Regulation | 2 | 2013 | 198 | 0.190 |
Why?
|
| Humans | 9 | 2020 | 28121 | 0.180 |
Why?
|
| T-Box Domain Proteins | 1 | 2020 | 8 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 2 | 2020 | 345 | 0.180 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 35 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2020 | 132 | 0.170 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2020 | 20 | 0.170 |
Why?
|
| Carcinogenesis | 1 | 2020 | 84 | 0.170 |
Why?
|
| Survival Analysis | 1 | 2020 | 289 | 0.160 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2019 | 10 | 0.160 |
Why?
|
| Animals | 3 | 2019 | 10399 | 0.150 |
Why?
|
| Disease Progression | 1 | 2019 | 473 | 0.140 |
Why?
|
| Neoplasms | 2 | 2019 | 818 | 0.130 |
Why?
|
| Time Factors | 1 | 2020 | 1593 | 0.130 |
Why?
|
| Mice | 2 | 2019 | 4645 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2019 | 1324 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2012 | 103 | 0.110 |
Why?
|
| Cell Movement | 2 | 2013 | 369 | 0.110 |
Why?
|
| Apoptosis | 3 | 2012 | 771 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1570 | 0.110 |
Why?
|
| Molecular Sequence Data | 2 | 2012 | 1050 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 1 | 2013 | 190 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2019 | 1433 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2012 | 23 | 0.100 |
Why?
|
| Male | 3 | 2019 | 13487 | 0.100 |
Why?
|
| Leukemia | 1 | 2012 | 30 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 575 | 0.090 |
Why?
|
| Tumor Microenvironment | 1 | 2013 | 179 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 102 | 0.090 |
Why?
|
| Up-Regulation | 1 | 2012 | 245 | 0.090 |
Why?
|
| Colonic Neoplasms | 1 | 2012 | 121 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 689 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 464 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2012 | 28 | 0.050 |
Why?
|
| Base Sequence | 2 | 2012 | 584 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2020 | 13 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 58 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 451 | 0.040 |
Why?
|
| Female | 1 | 2012 | 15156 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 50 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 49 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 86 | 0.020 |
Why?
|
| HT29 Cells | 1 | 2012 | 20 | 0.020 |
Why?
|
| Osteosarcoma | 1 | 2012 | 16 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 133 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2012 | 315 | 0.020 |
Why?
|
| DNA Primers | 1 | 2012 | 146 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 326 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2012 | 77 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 134 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 198 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 161 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2012 | 478 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 288 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 510 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2012 | 656 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 414 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 402 | 0.020 |
Why?
|
| Prognosis | 1 | 2012 | 803 | 0.020 |
Why?
|
| Protein Binding | 1 | 2012 | 656 | 0.020 |
Why?
|